ATXN3 and Huntington disease: The reduction in cell death induced by treatment with lithium carbonate in cells expressing expanded ATX3 demonstrated in our study is further evidence of the therapeutic potential of lithium in polyglutamine diseases, as demonstrated in HD and SCA1 models.